Navigation Links
Caliper Life Sciences Launches LabChip(R) XT for Next Generation Sequencing Applications
Date:2/19/2010

HOPKINTON, Mass., Feb. 19 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. (Nasdaq: CALP), a leading provider of tools and services for drug discovery and life sciences research, today introduced the LabChip XT, an automated nucleic acid fractionation instrument.  The solution removes a key bottleneck in the current workflow for next generation sequencing by replacing the tedious gel isolation and purification steps used for size selection of sheared genomic DNA.  The LabChip XT and its integrated software utilize a multi-channel microfluidic chip to quickly process samples independently and without the potential for cross contamination.

"The LabChip XT was developed in collaboration with leading sequencing centers and providers of next generation sequencing instrumentation and chemistries," said Kevin Hrusovsky, President and CEO, Caliper Life Sciences.  "We are confident that the LabChip XT, the first product Caliper is introducing to the sequencing market, will improve sample preparation efficiency and downstream data processing—two critical elements for next-gen sequencing. We are collaborating with our newly formed Sequencing Science Advisory Board to demonstrate these sequencing workflow improvements as well as to develop additional technology platforms in this sector."

The LabChip XT will be presented at the 2010 Advances in Genome Biology and Technology (AGBT) conference, February 24 – 27 in Marco Island, Florida. For additional information on the LabChip XT or to learn more about the XT Early Access Program, please visit Caliper at AGBT or www.caliperls.com.

About Caliper Life Sciences

Caliper Life Sciences is a premier provider of cutting-edge technologies enabling researchers in the life sciences industry to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper is aggressively innovating new technology to bridge the gap between in vitro assays and in vivo results and then translating those results into cures for human disease. Caliper's portfolio of offerings includes state-of-the-art microfluidics, lab automation & liquid handling, optical imaging technologies, and discovery & development outsourcing solutions. For more information please visit www.caliperLS.com.

Caliper and LabChip are registered trademarks of Caliper Life Sciences, Inc.

SOURCE Caliper Life Sciences, Inc.

Back to top

RELATED LINKS
http://www.caliperls.com

'/>"/>

SOURCE Caliper Life Sciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Caliper Life Sciences Launches Living Image(R) 4.0 Software
2. Caliper Life Sciences Expands Suite of Reagents Supporting the IVIS Family of In Vivo Imaging Systems
3. Caliper Life Sciences Launches IVIS(R) In Vivo Imaging System with X-Ray
4. Caliper Life Sciences Reports Second Quarter 2009 Results
5. Caliper Life Sciences Second Quarter 2009 Financial Results Conference Call Notice
6. Caliper Life Sciences Introduces Staccato Protein Workstation for Automated Protein Sample Preparation & Analysis
7. Caliper Life Sciences to Webcast Investor Session of Open House
8. Caliper Life Sciences Reports First Quarter 2009 Results
9. Caliper Life Sciences Announces Date and Location of its 2009 Annual Meeting of Stockholders
10. EPA Presents Initial Results from Caliper Life Sciences ToxCast Screening Effort
11. Caliper Life Sciences Reports Fourth Quarter and Full Year 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... Dec. 3, 2016  In five studies being presented ... Annual Meeting and Exposition in San Diego ... to improve the delivery of life-saving treatments to patients ... are designed to carry therapies directly to the sites ... could provide a substantial advantage over traditional, systemic methods. ...
(Date:12/2/2016)... Dec. 2, 2016 Amgen (NASDAQ: AMGN ... announced the submission of a Marketing Authorization Application (MAA) to ... candidate to Avastin ® (bevacizumab). The companies believe this ... EMA. "The submission of ABP 215 to ... expand our oncology portfolio," said Sean E. Harper , ...
(Date:12/2/2016)... ... December 01, 2016 , ... Aerocom Healthcare ( ... hospitals, will present its chain-of-custody solution for tracking and securing medications at booth ... Dec. 4-8, 2016. , Aerocom has a proven solution for tracking medications via ...
(Date:12/2/2016)... ... December 02, 2016 , ... ... dedicated to collaboratively developing improved chemistry, manufacturing and control technologies for the ... UHPLC, with robust, probe-based sampling. , Online liquid chromatography analysis is ...
Breaking Biology Technology:
(Date:6/16/2016)... June 16, 2016 The ... expected to reach USD 1.83 billion by 2024, ... Research, Inc. Technological proliferation and increasing demand in ... expected to drive the market growth. ... The development of advanced multimodal techniques for ...
(Date:6/9/2016)... 2016  Perkotek an innovation leader in attendance control systems is proud to announce ... for employers to make sure the right employees are actually signing in, and to ... ... ... ...
(Date:6/7/2016)... , June 7, 2016  Syngrafii Inc. ... a business relationship that includes integrating Syngrafii,s patented ... branch project. This collaboration will result in greater ... the credit union, while maintaining existing document workflow ... http://photos.prnewswire.com/prnh/20160606/375871LOGO ...
Breaking Biology News(10 mins):